Lung Cancer News

A high percentage of people with cancer exhibit what are known as SPPADE symptoms, according to study results.

A combination of toripalimab and perioperative chemotherapy significantly extended EFS compared with chemotherapy alone among patients with resectable stage III non-small cell lung cancer, according to results of a randomized phase 3 study.

Most women with cancer experience some degree of sexual dysfunction, studies have shown, yet few are asked about sexual health before or during cancer treatment.

Pembrolizumab demonstrated clinical activity among patients with diffuse malignant peritoneal mesothelioma, regardless of PD-L1 status or histology, according to data published in JAMA Network Open.

Cancer Moonshot’s goal of reducing the cancer death rate by at least 50% over the next 25 years will depend upon greater access to and utilization of cancer prevention interventions, according to a study presented at an NCI press briefing.

Patricia M. LoRusso, DO, PhD (hc), has been elected president-elect of American Association for Cancer Research for 2023-2024.

Patients with resectable non-small cell lung cancer who received perioperative durvalumab with neoadjuvant chemotherapy had significantly longer EFS and higher pathologic complete response rates than those who received chemotherapy alone.

Cardiovascular disease, especially atherosclerotic CVD, was associated with increased risk for cancer diagnosis, according to a study published in JACC: CardioOncology.

The FDA announced several regulatory actions the past few weeks.

The number of individuals diagnosed with and treated for cancer in the United States decreased 14% during 2020 compared with the previous year, a study published in JAMA Surgery showed.